An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
1. Verfasser: | Bristy, Israt Zerin |
---|---|
Weitere Verfasser: | Kabir, Md. Tanvir |
Format: | Abschlussarbeit |
Sprache: | English |
Veröffentlicht: |
Brac University
2021
|
Schlagworte: | |
Online Zugang: | http://hdl.handle.net/10361/15619 |
Ähnliche Einträge
-
Molecules associated with the development of lung cancer
von: Rahman, Adree, et al.
Veröffentlicht: (2023) -
A case study of lung cancer patients in term of various risk factors in context of Bangladesh
von: Shabnam, Musharrat
Veröffentlicht: (2018) -
Immunotherapy in the Management of Lung Cancer
von: Tasnim, Humayra
Veröffentlicht: (2022) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
von: Paul, Pulock
Veröffentlicht: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
von: Mim, Shanzida
Veröffentlicht: (2023)